319 related articles for article (PubMed ID: 7596051)
1. Prognostic factors for loco-regional control and outcome of re-irradiation for patients with poorly-differentiated squamous cell carcinoma of the nasopharynx.
Mitsuhashi N; Sakurai H; Takahashi M; Maebayashi K; Tamaki Y; Hashida I; Akimoto T; Nakamoto S; Takahashi T; Hayakawa K
Jpn J Clin Oncol; 1995 Jun; 25(3):72-8. PubMed ID: 7596051
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of poorly-differentiated squamous cell carcinoma of the nasopharynx.
Mitsuhashi N; Niibe H; Hayakawa K; Tamaki Y; Takahashi M; Yamakawa M; Hashida I; Akimoto T; Kiryu Y
Jpn J Clin Oncol; 1994 Aug; 24(4):191-8. PubMed ID: 8072197
[TBL] [Abstract][Full Text] [Related]
3. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors.
To EW; Lai EC; Cheng JH; Pang PC; Williams MD; Teo PM
Laryngoscope; 2002 Oct; 112(10):1877-82. PubMed ID: 12368634
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of prognostic factors in 106 cases of carcinoma of the rhinopharynx treated with cobalt teletherapy].
Zini G; Alberti G; Armaroli L; Barbieri E; Di Marzio G; Frezza G; Neri S; Silvano M; Babini L
Radiol Med; 1989 Nov; 78(5):430-4. PubMed ID: 2608930
[TBL] [Abstract][Full Text] [Related]
7. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
8. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
9. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
10. [Re-radiation of recurrent nasopharyngeal carcinoma--analysis of 58 cases].
Yao YZ
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):288-90. PubMed ID: 2625112
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
[TBL] [Abstract][Full Text] [Related]
12. [Lymphoepithelial carcinoma of the nasopharynx: the treatment results following radiotherapy].
Leicher-Düber A; Düber C; Kutzner J; Thelen M
Strahlenther Onkol; 1986 Nov; 162(11):698-703. PubMed ID: 3787454
[TBL] [Abstract][Full Text] [Related]
13. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
14. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S
J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331
[TBL] [Abstract][Full Text] [Related]
15. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
16. Salvage re-irradiation for recurrent head and neck cancer.
Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
[TBL] [Abstract][Full Text] [Related]
17. Nasopharyngeal carcinoma: treatment results with primary radiation therapy.
Bailet JW; Mark RJ; Abemayor E; Lee SP; Tran LM; Juillard G; Ward PH
Laryngoscope; 1992 Sep; 102(9):965-72. PubMed ID: 1518360
[TBL] [Abstract][Full Text] [Related]
18. [Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy].
Hu Y; Lu T; Mai W; Han F; Huang Y; Liu H; Zhang E
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):463-7. PubMed ID: 12761966
[TBL] [Abstract][Full Text] [Related]
19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: experience with 60 cases.
Hsu MM; Hong RL; Ting LL; Ko JY; Sheen TS; Lou PJ
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):798-802. PubMed ID: 11448353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
